Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020]

Respir Med. 2022 Jan:191:106065. doi: 10.1016/j.rmed.2020.106065. Epub 2020 Jun 11.
No abstract available

Keywords: Biologic; Persistent asthma; Treatment.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Biological Products*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • dupilumab